| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.08 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.08 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.09 |